ÂÜÀòÂÒÂ×

The Medical Affairs and Development team at Amolyt Pharma spearheads the clinical advancement and medical strategy of peptide treatments for rare endocrine and metabolic disorders. They ensure that all preclinical and clinical data align with regulatory standards, engage with global medical communities to communicate scientific insights, and drive initiatives to optimize patient outcomes and treatment adoption.